Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202308786657562Recruiting
Randomised, double-blind trial in Cardiovascular Malformation (CVM) comparing caffeine group with control placebo group (2 arms). Primary endpoint: Extubation time. Started Aug 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202308786657562.